178 related articles for article (PubMed ID: 2173855)
1. Measurement of immunoreactive prothrombin precursor and vitamin-K-dependent gamma-carboxylation in human hepatocellular carcinoma tissues: decreased carboxylation of prothrombin precursor as a cause of des-gamma-carboxyprothrombin synthesis.
Ono M; Ohta H; Ohhira M; Sekiya C; Namiki M
Tumour Biol; 1990; 11(6):319-26. PubMed ID: 2173855
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinomas.
Huisse MG; Leclercq M; Belghiti J; Flejou JF; Suttie JW; Bezeaud A; Stafford DW; Guillin MC
Cancer; 1994 Sep; 74(5):1533-41. PubMed ID: 7520347
[TBL] [Abstract][Full Text] [Related]
3. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.
Yamagata H; Nakanishi T; Furukawa M; Okuda H; Obata H
J Gastroenterol Hepatol; 1995; 10(1):8-13. PubMed ID: 7620113
[TBL] [Abstract][Full Text] [Related]
4. Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma.
Ono M; Ohta H; Ohhira M; Sekiya C; Namiki M
Am J Gastroenterol; 1990 Sep; 85(9):1149-54. PubMed ID: 1697141
[TBL] [Abstract][Full Text] [Related]
5. Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study.
Okuda H; Obata H; Nakanishi T; Furukawa R; Hashimoto E
J Hepatol; 1987 Jun; 4(3):357-63. PubMed ID: 3036940
[TBL] [Abstract][Full Text] [Related]
6. Process of carboxylation of glutamic acid residues in the gla domain of human des-gamma-carboxyprothrombin.
Uehara S; Gotoh K; Handa H; Honjo K; Hirayama A
Clin Chim Acta; 1999 Nov; 289(1-2):33-44. PubMed ID: 10556651
[TBL] [Abstract][Full Text] [Related]
7. Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma.
Tsai SL; Huang GT; Yang PM; Sheu JC; Sung JL; Chen DS
Hepatology; 1990 Mar; 11(3):481-8. PubMed ID: 2155866
[TBL] [Abstract][Full Text] [Related]
8. Early processing of prothrombin and factor X by the vitamin K-dependent carboxylase.
Wallin R; Martin LF
J Biol Chem; 1988 Jul; 263(20):9994-10001. PubMed ID: 3290218
[TBL] [Abstract][Full Text] [Related]
9. The acquired vitamin K-dependent gamma-carboxylation deficiency in hepatocellular carcinoma involves not only prothrombin, but also protein C.
Yoshikawa Y; Sakata Y; Toda G; Oka H
Hepatology; 1988; 8(3):524-30. PubMed ID: 2836289
[TBL] [Abstract][Full Text] [Related]
10. Propeptide recognition by the vitamin K-dependent carboxylase in early processing of prothrombin and factor X.
Wallin R; Turner R
Biochem J; 1990 Dec; 272(2):473-8. PubMed ID: 2268273
[TBL] [Abstract][Full Text] [Related]
11. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.
Weitz IC; Liebman HA
Hepatology; 1993 Oct; 18(4):990-7. PubMed ID: 8406374
[TBL] [Abstract][Full Text] [Related]
12. Vitamin K-dependent carboxylation. A synthetic peptide based upon the gamma-carboxylation recognition site sequence of the prothrombin propeptide is an active substrate for the carboxylase in vitro.
Ulrich MM; Furie B; Jacobs MR; Vermeer C; Furie BC
J Biol Chem; 1988 Jul; 263(20):9697-702. PubMed ID: 3133366
[TBL] [Abstract][Full Text] [Related]
13. The vitamin K-dependent carboxylation system in human osteosarcoma U2-OS cells. Antidotal effect of vitamin K1 and a novel mechanism for the action of warfarin.
Wallin R; Rossi F; Loeser R; Key LL
Biochem J; 1990 Jul; 269(2):459-64. PubMed ID: 2386486
[TBL] [Abstract][Full Text] [Related]
14. Specificity of increased des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection.
Lefrère JJ; Gozin D; Soulier JP; Bettan L; Mavier P; Dhumeaux D; Guillaumont M; Leclercq M
J Hepatol; 1987 Aug; 5(1):27-9. PubMed ID: 2821104
[TBL] [Abstract][Full Text] [Related]
15. Studies in rats on in vitro inhibition and in vivo activity of vitamin-K-dependent carboxylation.
Cocchetto DM; Bjornsson TD
Haemostasis; 1986; 16(5):321-36. PubMed ID: 3781349
[TBL] [Abstract][Full Text] [Related]
16. Roles and Signaling Pathways of Des-γ-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma.
Cui SX; Yu XF; Qu XJ
Cancer Invest; 2016 Oct; 34(9):459-464. PubMed ID: 27673353
[TBL] [Abstract][Full Text] [Related]
17. A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma.
Soulier JP; Gozin D; Lefrere JJ
Gastroenterology; 1986 Nov; 91(5):1258-62. PubMed ID: 3019818
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K-dependent carboxylase: the carboxylation of exogenous substrates in different systems.
de Boer-van den Berg MA; Ulrich MM; Hemker HC; Soute BA; Vermeer C
Biochim Biophys Acta; 1985 Sep; 831(1):94-8. PubMed ID: 4041466
[TBL] [Abstract][Full Text] [Related]
19. Vitamin K dependent in vitro production of prothrombin.
Swanson JC; Suttie JW
Biochemistry; 1982 Nov; 21(23):6011-8. PubMed ID: 6758841
[TBL] [Abstract][Full Text] [Related]
20. Des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection.
Buffet C; Bismuth E; Hagege H; Etienne JP
Dig Dis Sci; 1989 Jun; 34(6):963-4. PubMed ID: 2470560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
